| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/06/2001 | WO2001034647A3 Animal collagens and gelatins |
| 12/06/2001 | WO2001034646A3 Recombinant gelatins |
| 12/06/2001 | WO2001032879A3 Method for producing recombinant interleucin-8 and interleucin-8 muteins |
| 12/06/2001 | WO2001032864A3 Gpcr-kd5 polypeptides and dna sequences thereof |
| 12/06/2001 | WO2001030991A3 Human narcolepsy gene |
| 12/06/2001 | WO2001030854A3 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 12/06/2001 | WO2001030376A3 Use of urodilatin for treating chronic kidney failure with residual kidney functions |
| 12/06/2001 | WO2001027630A3 Methods to identify compounds that modulate neuronal activity |
| 12/06/2001 | WO2001027313A3 Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 2 gene |
| 12/06/2001 | WO2001027150A3 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 12/06/2001 | WO2001023594A3 Enhanced stress tolerance in maize via manipulation of cell cycle regulatory genes |
| 12/06/2001 | WO2001023553A9 Metastasis-associated antigen c4.4a |
| 12/06/2001 | WO2001023421B1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 12/06/2001 | WO2001021653A3 Ovarian tumor antigen and methods of use therefor |
| 12/06/2001 | WO2001018042A3 Apoptosis proteins |
| 12/06/2001 | WO2001016307A3 Plant promoter sequences from maize for selective control of gene expression |
| 12/06/2001 | WO2001014416A3 Synthetic papillomavirus genes optimized for expression in human cells |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001012662A3 Membrane associated proteins |
| 12/06/2001 | WO2000077233A3 Complement-resistant non-mammalian dna viruses and uses thereof |
| 12/06/2001 | WO2000077206A3 The myostatin gene promoter and inhibition of activation thereof |
| 12/06/2001 | WO2000072868A3 Peptides for therapeutic use |
| 12/06/2001 | WO2000063427A3 Compound screening method |
| 12/06/2001 | WO2000061750A3 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 12/06/2001 | WO2000050443A9 Secreted proteins and uses thereof |
| 12/06/2001 | WO2000025804A9 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 12/06/2001 | WO2000011166A9 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
| 12/06/2001 | WO2000011036A9 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
| 12/06/2001 | WO2000006599A8 Inhibitors of hiv membrane fusion |
| 12/06/2001 | US20010049834 A polynucleotide sequence comprising the cDNA insert which encodes a polypeptide with PR1-C10 like activity; genetic engineerig |
| 12/06/2001 | US20010049832 Introducing into plant cell a recombinant expression cassette comprising a root transcriptional factor polynucleotide operably linked to a promoter, culturing the plant cell, inducing expression of polynuceotide to code the polypeptide |
| 12/06/2001 | US20010049831 Contacting a plant cell with a vector containing a nucleic acid sequence comprising a structural gene encoding FT polypeptide, operably associated with a promoter, to obtain transformed plant cell, producing plant from transformed cell |
| 12/06/2001 | US20010049830 Molecular farming |
| 12/06/2001 | US20010049435 Myostatin gene promoter and inhibition of activation thereof |
| 12/06/2001 | US20010049432 Human semaphorin ZSMF-16 |
| 12/06/2001 | US20010049393 Methods for defining MYC target genes and uses thereof |
| 12/06/2001 | US20010049357 Promotes dendritic cell maturation in vitro. |
| 12/06/2001 | US20010049356 Method of preparing fetuin to induce apoptosis |
| 12/06/2001 | US20010049355 Providing exogenous SLED to endothelial cells; maybe be provided systemically, topically, or via a vector comprising a SLED expression cassette |
| 12/06/2001 | US20010049144 Genetically engineering a primate for expression of a desired gene, comprising introducing into the primate a transgene of a Rous Sarcoma Virus promoter (RSV) and a nucleic acid sequence heterologous to said RSV promoter; gene therapy |
| 12/06/2001 | US20010049137 DNA fragments derived from the genomic DNA of HPV-33, including recombinant vectors, which cells are replicated in host cells and expressed as immunogenic proteins; diagnosis of tumors; antibodies to detect viral infections |
| 12/06/2001 | US20010049136 Deletion of: all or part of the E1A regions, the E1B region coding for the early proteins, E2 or E4 regions, the E1a region and encapsidation region; gene therapy |
| 12/06/2001 | US20010049122 For reducing inflammation, for treating an autoimmune disease, for enhancing transplantation of tissue grafts, increasing antitumor immunity, and inhibiting viral and parasitic infections |
| 12/06/2001 | US20010049121 Polypeptides and polynucleotides; drug screening, use in therapy, diagnostic assays |
| 12/06/2001 | US20010049120 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
| 12/06/2001 | US20010049093 Inhibition of viral gene activities |
| 12/06/2001 | US20010048929 Novel multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 12/06/2001 | US20010048928 Herpesvirus particles comprising fusion protein and their preparation and use |
| 12/06/2001 | US20010048927 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
| 12/06/2001 | US20010048924 Method for inhibiting cerebral tissue factor mediated reperfusion damage |
| 12/06/2001 | DE10027119A1 Photolithographic exposure unit for e.g. manufacturing DNA chips, scans target areas of biological material selectively with highly-focused flying spot illumination |
| 12/06/2001 | DE10026845A1 Triacylglycerol-Lipasen Triacylglycerol lipases |
| 12/06/2001 | DE10026713A1 Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta Mutein of a chain of a protein from the superfamily of the growth factor TGF-beta |
| 12/06/2001 | DE10025620A1 New nucleic acid encoding chimeric potassium channel protein, useful, when immobilized on carrier, in screening agents for toxicity and pharmaceutical activity |
| 12/06/2001 | DE10025521A1 Tumor-assoziiertes Antigen B132 Tumor-associated antigen B132 |
| 12/06/2001 | CA2423502A1 Triacylglycerol lipases from arabidopsis thaliana |
| 12/06/2001 | CA2415225A1 Composition and method for enhancing elasticity of tissue |
| 12/06/2001 | CA2414125A1 Bartonella henselae virb operon and proteins encoded thereby |
| 12/06/2001 | CA2411667A1 Ghrelin analogs |
| 12/06/2001 | CA2411655A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2411304A1 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | CA2411040A1 Therapeutic anti-melanoma compounds |
| 12/06/2001 | CA2410981A1 Adenovirus particles with mutagenized fiber proteins |
| 12/06/2001 | CA2410949A1 Novel target genes for diseases of the heart |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | CA2410895A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410883A1 Methods for isolating and using fungal hemolysins |
| 12/06/2001 | CA2410865A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410762A1 Feline hepatocyte growth factor |
| 12/06/2001 | CA2410758A1 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 12/06/2001 | CA2410754A1 Phosphorylated polypeptides and uses related thereto |
| 12/06/2001 | CA2410736A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | CA2410735A1 Use of adnf for enhancing learning and memory |
| 12/06/2001 | CA2410734A1 Dnas encoding mammalian histamine receptor of the h4 subtype |
| 12/06/2001 | CA2410624A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/06/2001 | CA2410543A1 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 12/06/2001 | CA2410515A1 Method of identifying and/or isolating stem cells |
| 12/06/2001 | CA2410489A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | CA2410485A1 Thrombospondin-1 type 1 repeat polypeptides |
| 12/06/2001 | CA2410453A1 Neuroprotective peptides |
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2410051A1 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 12/06/2001 | CA2409964A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 12/06/2001 | CA2409924A1 Convergent combinatory peptide libraries and their use for vaccination against hepatitis c virus |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/06/2001 | CA2409188A1 Polyubiquitin based hydrogel and uses thereof |
| 12/06/2001 | CA2401974A1 Dna expression vectors and methods of use |
| 12/06/2001 | CA2400777A1 Process for the fermentative preparation of l-threonine |
| 12/05/2001 | EP1160326A1 Mutant PLK protein and gene encoding the same |
| 12/05/2001 | EP1160323A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
| 12/05/2001 | EP1160322A2 Human melanocyte stimulating hormone receptors |
| 12/05/2001 | EP1160321A1 Kidney Injury Novel Gene-1: Isolation and therapeutic applications |
| 12/05/2001 | EP1160320A1 Use of hTAFII80 and isoforms thereof for inducing apoptosis |
| 12/05/2001 | EP1160256A2 Monoclonal antibody specific for beta-A4 peptide |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |
| 12/05/2001 | EP1160253A1 A gene encoding a polypeptide having pre-B cell growth-supporting ability |
| 12/05/2001 | EP1159975A2 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159974A1 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159620A1 Detection of mtoc disrupting substances |